IMC Chicago’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.48M Buy
68,900
+500
+0.7% +$48.7K ﹤0.01% 2148
2026
Q2
$7.33M Buy
+68,400
New +$4.48M ﹤0.01% 1788
2025
Q2
– Sell
-3,020
Closed -$327K – 3272
2025
Q1
$327K Buy
+3,020
New +$263K ﹤0.01% 2879
2024
Q4
– Sell
-5,552
Closed -$545K – 3115
2024
Q3
$545K Buy
5,552
+4,272
+334% +$552K ﹤0.01% 2375
2024
Q2
$209K Buy
+1,280
New +$182K ﹤0.01% 2582

Other funds holding AGL

IMC Chicago's AGL Position: Q3 2026 in Review

IMC Chicago reduced its Agilon Health (AGL) stake by 20% in Q3 2026, selling an estimated $179K and leaving 7,542 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #4477.

IMC Chicago first reported a position in AGL in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.01M in Q2 2026. 180 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • IMC Chicago held 7,542 shares of Agilon Health worth $600K as of Q3 2026.
  • IMC Chicago sold 1,837 Agilon Health shares in Q3 2026, an estimated $179K.
  • Agilon Health made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4477 holding.
  • IMC Chicago first reported a position in Agilon Health in Q3 2024 and has held it in 3 quarters since.
  • IMC Chicago's Agilon Health position peaked at $1.01M in Q2 2026.
  • 180 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.